Safety Problems With a Transdermal Patch for Migraine: Lessons From the Development, Approval, and Marketing Process

Healing an ailing pharmaceutical system: prescription for reform for United States and Canada

(2018) Adam Gaffney et al.   BMJ-British Medical Journal

Healing an ailing pharmaceutical system: prescription for reform for United States and Canada

(2018) Adam Gaffney et al.   BMJ-British Medical Journal

Social Media Listening for Routine Post-Marketing Safety Surveillance

(2016) Gregory E. Powell et al.   DRUG SAFETY

A Sumatriptan Iontophoretic Transdermal System for the Acute Treatment of Migraine

(2012) Jerome Goldstein et al.   HEADACHE

Twelve-Month Tolerability and Efficacy Study of NP101, the Sumatriptan Iontophoretic Transdermal System

(2012) Timothy R. Smith et al.   HEADACHE

Low Efficacy of Transdermal Sumatriptan in Migraine

(2011) Peer Tfelt-Hansen   CNS DRUGS

Combination products neglected by FDA device evaluation

(2011) Hannah Waters   NATURE MEDICINE

Evaluation and Registration of Adverse Events in Clinical Drug Trials in Migraine

(2008) P Tfelt-Hansen et al.   CEPHALALGIA

Drug-Review Deadlines and Safety Problems

(2008) Daniel Carpenter et al.   NEW ENGLAND JOURNAL OF MEDICINE